Dataset Information


Whole-blood transcriptomic profiling highlights rituximab response in rheumatoid arthritis

ABSTRACT: Objective: We performed whole-blood transcriptomic profiling for patients with rheumatoid arthritis (RA) who received rituximab (RTX). We aimed to identify a molecular signature that could predict the clinical response to RTX and transcriptomic changes after RTX therapy. Methods: We performed a microarray assay of the whole human genome with RNA from a peripheral blood sample taken before the first RTX cycle from 68 patients included in the SMART study (24 EULAR non-responders and 44 responders at week 24). The transcriptomic profile was also assessed 24 weeks after the first RTX administration

ORGANISM(S): Homo sapiens  

SUBMITTER: S Jacques   J Tebib  G Chiocchia  J Sibilia  S Marion-Thore  X L Loët  X Mariette  F Dumont  J Sellam  S Rouanet  Y Taoufik  B Combe  H-J Garchon  Florent Dumont  H Chavez  M Dougados 

PROVIDER: E-GEOD-54629 | ArrayExpress | 2015-01-01



Similar Datasets

2006-03-06 | E-GEOD-4351 | ArrayExpress
2012-04-09 | E-GEOD-37107 | ArrayExpress
2009-10-02 | GSE15316 | GEO
2009-09-18 | E-GEOD-15258 | ArrayExpress
2009-09-14 | GSE15258 | GEO
| GSE24742 | GEO
2005-11-23 | GSE3647 | GEO
2013-06-13 | E-GEOD-47871 | ArrayExpress
2010-10-19 | E-GEOD-24742 | ArrayExpress
2008-11-28 | GSE10846 | GEO